Form D · Private Equity Fund

Abingworth Bioventures 9 LP

Washington, DC · CIK 0001986435

Offering snapshot reported Dec 19, 2025 · SEC filing

Reported sold
$320M
Indefinite offering
Investors reported
29
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 22, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$160M$320MDec 21, 2023Dec 23, 2024: $220,050,000.00Dec 23, 2024Dec 19, 2025: $320,300,000.00Dec 19, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$220,050,000 → $320,300,000
  • Reported investors22 → 29

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 19, 2025Amendment$320,300,000$100,250,000vs Dec 23, 202429SEC filing
Dec 23, 2024Amendment$220,050,000No comparison22SEC filing
Dec 21, 2023InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$4M (estimated)
Finders' fees
$0
Form D file number
021-500399
Total Amount Sold includes sales made by ABV 9 - EU, S.C.Sp
Certain employees of an affiliate of the GP ("Carlyle") receive compensation in part based on the capital raised; such compensation is borne by Carlyle, not the Fund's investors.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
TCG Capital Markets L.L.C.291767TCG Capital Markets L.L.C. · CRD 291767
Asante Capital Group Advisors, LLC155178Asante Capital Group Advisors, LLC · CRD 155178

Source: Form D, filed Dec 19, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Abv 9 Gp Lp Promoter
N/A Abv 9 Holdings, L.L.C. Promoter
Jeremy Anderson Executive
Christina Gibbs Executive
David Lobe Executive
Elizabeth Muscarella Executive
Rob Rosen Executive
Robert Rosen Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
1001 Pennsylvania Avenue, Nw Suite 220 South
Washington, DC, 20004